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Abstract 
Background: Falciparum malaria is an important risk factor for African Burkitt lymphoma (BL), but few studies have 
evaluated malaria patterns in healthy BL-age children in populations where both diseases are endemic. To obtain 
accurate current data, patterns of asymptomatic malaria were investigated in northern Uganda, where BL is endemic.
Methods: Between 2011 and 2015, 1150 apparently healthy children under 15 years old were sampled from 100 
villages in northern Uganda using a stratified, multi-stage, cluster survey design. Falciparum malaria prevalence (pfPR) 
was assessed by questionnaire, rapid diagnostic test (RDT) and thick film microscopy (TFM). Weighted pfPR and 
unadjusted and adjusted associations of prevalence with covariates were calculated using logistic models and survey 
methods.
Results: Based on 1143 children successfully tested, weighted pfPR was 54.8% by RDT and 43.4% by TFM. RDT 
sensitivity and specificity were 97.5 and 77.8%, respectively, as compared to TFM, because RDT detect malaria anti-
gens, which persist in peripheral blood after clinical malaria, thus results based on RDT are reported. Weighted pfPR 
increased from 40% in children aged under 2 years to 61.8% in children aged 6–8 years (odds ratio 2.42, 95% confi-
dence interval (CI) 1.26–4.65), then fell slightly to 49% in those aged 12–15 years. Geometric mean parasite density 
was 1805.5 parasites/µL (95% CI 1344.6–2424.3) among TFM-positive participants, and it was higher in children 
aged <5 years at 5092.9/µL (95% CI 2892.7–8966.8) and lower in those aged ≥10 years at 983.8/µL (95% CI 472.7–
2047.4; P = 0.001). Weighted pfPR was lower in children residing in sub-regions employing indoor residual spray-
ing (IRS) than in those residing in non-IRS sub-regions (32.8 versus 65.7%; OR 0.26, 95% CI 0.14, 0.46). However, pfPR 
varied both within IRS (3.2–55.3%) and non-IRS sub-regions (29.8–75.8%; Pheterogeneity <0.001). pfPR was inversely 
correlated with a child’s mother’s income (P = 0.011) and positively correlated with being enrolled in the wet season 
(P = 0.076), but sex was irrelevant.
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Background
Falciparum malaria is an important cause of childhood 
morbidity and mortality in young children in Equatorial 
Africa [1, 2]. It is also an important risk factor for Afri-
can Burkitt lymphoma (BL) [3], a B cell tumour that is 
the most common cancer in children in many countries 
in Equatorial Africa [4], including Uganda. The associa-
tion of falciparum malaria with BL is based on the geo-
graphical correlation of high incidence of severe malaria 
and high incidence of BL [5–7], and on the significant 
positive or inverse association of high titres of particu-
lar malaria antibodies in children with BL [8–10]. The 
epidemiological evidence is supported by evidence from 
mouse studies, which have shown that infection of mice 
with Plasmodium chabaudi increases the risk of genetic 
abnormalities in their B cells, including those similar to 
the characteristic abnormalities seen in BL involving the 
translocation of exons in the MYC gene on chromosome 
8 into the vicinity of enhancer or promoter regions for 
immunoglobulin genes on chromosomes 14, 2, or 22 [11, 
12].
Whether clinical malaria or the significantly more 
prevalent asymptomatic parasitaemia similarly affect BL 
risk is unknown [3]. The overlap between severe malaria 
and BL by age is imperfect [1, 2] because severe malaria 
occurs most commonly in young children of around 2 
years old [13], whereas BL peaks in children around 6–9 
years old [14, 15]. Since BL is an extremely fast-growing 
tumour [16], the imperfect overlap between the peak 
ages for severe malaria and BL does not support the idea 
that severe malaria is the antigenic insult that triggers BL 
onset. This reasoning is supported by the casual obser-
vations that a history of severe malaria is not a com-
monly elicited feature in children with BL suggesting 
that older children in the age range of BL are protected 
against severe malaria by acquired immunity [17, 18] in 
agreement with findings that the probability of clinical 
malaria falls by 6% per year of age and by 2% per episode 
of clinical malaria [19]. Thus, the timing of peak BL risk is 
consistent with recurrent mild or asymptomatic malaria 
parasitaemia being the malaria insults that triggers the 
onset of the genetic abnormalities that lead to BL.
Clarifying the malaria phenotype that is relevant for 
BL aetiology is an important question that remains unan-
swered because research efforts are hampered by the 
lack of reliable data about malaria experience among 
children of a similar age and sex distribution as BL cases 
living in BL-endemic areas. To address this knowledge 
gap, detailed epidemiological data and biological samples 
were collected from a representative population-based 
sample of healthy children from northern Uganda with a 
similar age and sex distribution as typical BL cases. This 
area has historically experienced holoendemic malaria 
[20–22] (weighted Plasmodium falciparum parasite prev-
alence (pfPR) over 75%) [22] and high incidence of BL [7]. 
Baseline data from field-collected data were analysed to 
obtain a more granular picture of the geographical and 
demographical patterns of asymptomatic malaria infec-
tion in this region. This would pave the way for follow-up 
studies conducted using molecular and immunological 
methods to evaluate  the malaria response in patients 
with and without BL and to perform more precise adjust-
ment of the geographical and demographical co-factors.
Methods
The aim, design and setting of the study
To obtain geographically and demographically represent-
ative data about malaria in northern Uganda, between 
January 2011 and April 2015, apparently healthy children 
(0–15 years of age) from the northwest and north-central 
regions of Uganda were enrolled as part of the EMBLEM 
study of BL [23]. These two regions were selected because 
they have historically experienced holoendemic malaria 
transmission [20] and they experience a correspondingly 
high, albeit geographically variable, BL endemicity [7]. 
The annual entomological inoculation rate (AEIR) var-
ies from 397 in  the Arua District in the northwest region 
to 1586, the highest number recorded worldwide, in  the 
Apac District in the north-central region [24]. Between 
2009 and 2012, the Government of Uganda responded to 
this high AEIR by implementing indoor residual spraying 
(IRS) of insecticides and distributing insecticide-treated 
bed nets to pregnant women and children under 5 years 
old in 10 districts in the north-central region, hereafter 
called the IRS sub-region [21]. The non-sprayed area is 
called the non-IRS sub-region.
Sampling design
A stratified multi-stage cluster sampling design was used 
to select a regionally representative, population-based 
Conclusions: The study observed high but geographically and demographically heterogenous patterns of asymp-
tomatic malaria prevalence among children living in northern Uganda. These results provide important baseline data 
that will enable precise evaluation of associations between malaria and BL.
Keywords: Burkitt lymphoma, Africa, Plasmodium falciparum, Malaria, Epidemiology, Non-Hodgkin lymphoma, 
Uganda
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sample of healthy children ages 0–15 years old from was 
selected 100 villages in the study region (Fig. 1). To select 
the villages, 100 census enumeration areas (EAs) were 
selected from a complete list of EAs in the study region 
obtained from the Uganda Bureau of Statistics (UBOS) 
[25]. This EA sample frame was stratified on ‘low-density’ 
versus ‘high-density’ population and ‘near water’ versus 
‘far from water’ before sampling. Since the stratifying 
variables are thought to influence mosquito ecology and 
through that malaria transmission [26, 27], they were 
considered domains of special interest when estimating 
geographical patterns of malaria. Low-density EA stra-
tum, considered a surrogate for rural areas, was defined 
as including those EAs having a population count of 
children younger than 15 years fewer than the EA mean 
population count (n  =  2683) [25]; otherwise the EAs 
were categorized as belonging to a high-density EA stra-
tum, considered a surrogate for urban areas. Near water 
EA stratum was defined as including those EAs with a 
boundary next to or within 500  m of an all-season sur-
face water body (a swamp, river, lake), based on distances 
estimated from national maps incorporating geographi-
cal information metadata; otherwise the EAs were cat-
egorized as belonging to a far from water EA stratum. 
Because 90% of the Ugandan population resides in rural 
(or low-density) areas, the high-density EA stratum were 
oversampled by selecting low-density: high-density EAs 
in a ratio of 2:1. Thus, 68 EAs were sampled from low-
density strata and 32 EAs from high-density with equal 
probability in each stratum, maintaining a ratio of 1:1 
for near water versus far from water EAs within each 
stratum.
Because the EAs are large geographical areas that were 
logistically challenging for research staff to accurately 
survey, they were segmented into four to 17 units per 
EA using existing local administrative units called Local 
Council 1 (LC-1), also known as villages and that have 
distinct non-overlapping boundaries, as segments. One 
segment was randomly selected with equal probability per 
EA. Thus, one segment or village represented the entire 
EA. In the next stage, 22–25 households per segment 
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Fig. 1 Flow chart showing the sampling of healthy children aged 0–15 years from 100 villages in north-central and northwest regions of Uganda 
between January 2011 and April 2015
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list constructed by study staff. In the third stage, four to 
25 children were selected from a list of all children in the 
selected households in that segment, based on residing in 
the study region for at least 4 months and according to the 
predetermined age and sex frequency distribution of typi-
cal BL cases in the region [7].
Participant enrolment
Experienced fieldwork teams visited participants in their 
homes and invited them to participate in the study after 
obtaining informed consent. Structured questionnaires 
were used to collect participant information about the 
demographics and household characteristics, educational 
level of a child’s parents, a child’s exposure to malaria 
suppression methods (use of mosquito bed nets the night 
before interview and use of IRS in the house), and his-
tory of outpatient or inpatient malaria treatment (up to 
6 months ago, 7–12 months ago, or 13 or more months 
ago). A venous blood sample for immediate malaria test-
ing and for storage for future studies was obtained from 
the participant child using EDTA tubes.
Malaria testing
Malaria infection was diagnosed by experienced labora-
tory technicians using thick film microscopy (TFM) to 
identify asexual malaria parasite forms in thick film slides 
stained with 10% Giemsa solution for 10  min. Malaria 
parasites were counted against 200 white blood cells 
(WBCs) and standardized to parasites/µL of blood based 
on the measured WBC/µL. Thin film smears were exam-
ined to identify Plasmodia species. Since  ~98% were P. 
falciparum, this species is assumed hereafter. The techni-
cians also used antigen–antibody capture rapid diagnos-
tic tests (RDT) (MALARIA DUAL kits, ICT Diagnostics, 
Muizenberg, Cape Town, South Africa) to diagnose 
malaria infection. These kits detect the P. falciparum-
specific malaria histidine-rich protein 2 (Pf-HRP2) and 
the pan-lactate dehydrogenase (pLDH) antigen shared by 
other Plasmodia that parasitize humans. The sensitivity 
and specificity of the kits for malaria in clinical samples 
in Uganda was reported to be 92–100% [28], which is 
adequate for the objectives of assessing epidemiological 
patterns of malaria in the current study. As only 2.1% of 
the children studied had fever at the time of enrolment, 
this number was considered negligible and unlikely to 
impact the overall results so these children were not 
excluded. The children with fever and positive RDT 
or TFM were treated for possible clinical malaria with 
artemisinin-based combination therapy (ACT) as first 
line drug for treatment of mild clinical malaria following 
national treatment guidelines. Parents of children with-
out symptoms were advised to seek treatment from their 
local health centre if a new fever developed.
Data management
Questionnaires were edited in the field and computerized 
using DataFax and the data submitted via a secure share-
portal to Information Management Services, Inc. (IMS, 
Calverton, MD, USA) to generate analysis files.
Statistical analysis
Descriptive analyses of pfPR, based on RDT, by geo-
graphical and demographical characteristics of partici-
pants are reported. To obtain regionally representative 
results, prevalence estimates were calculated as weighted 
probabilities of selecting the children in the study sam-
ple using standard survey statistical packages [29, 30] 
implemented in R (version 3.2.3). Details of the calcu-
lation of sampling weights are described in Additional 
file 1: Appendix 1 and 2. Thus, the reported estimates are 
representative for all the children in this region and the 
variance estimation took the weights into account and 
accounted for the clustering of the sample of children in 
the segments (villages). Unadjusted and adjusted odds 
ratios (ORs), standard errors [31] and Wald-type 95% CIs 
(95% CIs) [32] of association of pfPR with each variable 
were calculated. The adjusted models included only those 
variables with P < 0.10. Because parasite load in asympto-
matic children is partly a function of cumulative acquired 
immunity to malaria, the overall geometric mean parasite 
density (GMPD) per µL were calculated and compared 
by sex and age using the Student’s t test statistic. As the 
objective of these analyses was to describe patterns to 
obtain granular baseline data for hypothesis generation, 
the results were not adjusted for multiple testing. Thus, a 
two-sided P < 0.05 was considered as evidence of statisti-
cal significance and values P < 0.10 as suggesting a trend. 
Analyses of malaria patterns were repeated separately 
using pfPR defined based on only TFM and on both TFM 
and RDT and similar results were obtained.
Results
Characteristics of study population
Overall, 2484 households were selected in 100 villages and 
2467 of them participated. From these households, 1167 
children were invited to participate and 1150 of them were 
enrolled, representing a weighted sample of 585,762 chil-
dren in the region. Consistent with the design, to select 
children with a typical age and gender distribution typical 
of BL, 44.6% children participating were 6–10 years old 
and 52.1% were males (Table 1). Consistent with the pre-
dominantly rural population of northern Uganda, 67.6% 
of the children lived in low-density villages and 89.3% 
lived in villages near water. By region, 60.8% were from 
the north-central region and 39.2% from the northwest 
region (the location of these regions is shown in Fig. 2a). 
With respect to malaria suppression, 32.9% lived in the 
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sub-region employing IRS and 67.1% in the non-IRS sub-
region (as defined in Fig. 2b). To further explore malaria 
variation in sub-regions, the study area was sub-divided 
into seven sub-regions based on boundaries that corre-
spond roughly to tribal areas (as shown in Fig.  2c). Two 
of these sub-regions, which contribute to the majority of 
BL cases in this region [7], contributed 50% of the study 
population. Some 28.9% of the children reportedly used a 
mosquito bed net on the night before interview, but 31.3% 
lived in houses using IRS, which is similar to the per cent 
living in an IRS sub-region. Regarding socio-economic 
status, 55.3% of mothers of participants had fewer than 
5 years of formal education and 55.7% had a monthly 
median income below 30,000 Ugandan shillings (equiva-
lent to  ~US$10). Regarding history of malaria, 63.5% of 
the participants reported a history of outpatient malaria 
treatment, with 55.6% reporting such treatment in the past 
12  months. Conversely, only 36.6% reported at least one 
inpatient treatment for malaria, defined as requiring some 
observation at a clinic or hospital, with 12.6% reporting 
such treatment in the past 12 months.
Weighted malaria prevalence and density
Malaria testing was successful for 1143 children; the 
seven children who failed were excluded from further 
analysis (Table  2). The weighted pfPR based on RDT 
was 54.8% (95% CI 47.3–62.4%) and it was 43.4% (36.1–
50.7%) based on TFM. As expected, the sensitivity of 
RDT was 97.5% and the specificity was 77.8%, compared 
to TFM. RDT is more sensitive than TFM because it 
detects malaria antigens, which can be detected during 
early infection and for up to 35–42 days after treatment 
of symptomatic cases due to persistence of antigens in 
peripheral blood [33]. Using positivity to both RDT and 
TFM to define current parasitaemia, the weighted pfPR 
of current parasitaemia was 42.3%. Conversely, using only 
Table 1 Weighted distribution of  characteristics of  appar-
ently healthy children aged 0–15 years enrolled between Jan-
uary 2011 and April 2015 from the north-central and north-
west regions of Uganda
N = 1150 Weighted % (95% CI)
Age group, years
 0–5 326 28.0 (25.0–31.0)
 6–10 572 44.6 (41.6–47.7)
 11–15 252 27.4 (23.7–31.1)
Sex
 Female 541 47.9 (44.4–51.4)
 Male 609 52.1 (48.6–55.6)
Proximity to water
 Far (>500 m) 486 10.7 (8.1–13.4)
 Near (≤500 m) 664 89.3 (86.6–91.9)
Population density
 Low (<2683 children) 753 67.6 (60.0–75.2)
 High (≥2683 children) 397 32.4 (24.8–40)
Season
 Dry season 731 69.9 (57.7–82.2)
 Wet season 419 30.1 (17.8–42.3)
Region
 North-central 697 60.8 (46.9–74.8)
 Northwest 453 39.2 (25.2–53.1)
Indoor residual spraying (IRS) sub-region
 Not an IRS district 737 67.1 (53.1–81.0)
 IRS district 413 32.9 (19.0–46.9)
Indoor residual spraying (IRS) in house
 More than a year ago 752 68.7 (55.8–81.6)
 In the past year 392 31.3 (18.4–44.2)
Sub-regions
 1 113 7.9 (2.6–13.2)
 2 289 22.6 (10.5–34.6)
 3 51 8.7 (0.5–17.9)
 4 97 9.6 (2.1–17.1)
 5 303 34.5 (20.0–49.0)
 6 90 2.3 (0.1–4.4)
 7 207 14.5 (4.5–24.5)
Mother’s education
 Up to primary 4 581 55.3 (49.5–61.0)
 Primary 5 or higher 565 44.7 (39.0–50.5)
Mother’s income (Ugandan shillings)
 <30,000 USHS 560 55.7 (48.8–62.6)
 ≥30,000 USHS 585 44.3 (37.4–51.2)
Mosquito net used last night
 No 777 71.1 (63.4–78.8)
 Yes 366 28.9 (21.2–36.6)
Inpatient malaria
 No 725 63.4 (57.3–69.5)
 Past 12 months 150 12.6 (9.2–16.0)
 More than 12 months 269 24 (17.7–30.3)
Table 1 continued
N = 1150 Weighted % (95% CI)
Outpatient malaria
 No 523 36.5 (28.5–44.5)
 Past 12 months 532 55.6 (47.5–63.6)
 More than 12 months 89 7.9 (5.6–10.3)
N shows unweighted numbers; totals in some categories may not add up to 
100% because of missing data. Dry season months were January to March 
and July to August; Wet season months were April to June and September 
to December. Mother’s income was estimated in Ugandan shillings (30,000 
Ugandan shillings are approximately equal to 10 US dollars). The survey 
estimates are weighted estimates that account for the differential probabilities 
in selecting the sample of children. Variance estimation takes the weights into 
account and also accounts for the clustering of the sample of children at the 
village level. The coefficient of variation of the final weights was 1.27 (defined as 
standard deviation/mean of the final weights)
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RDT positivity to define malaria antigenaemia alone (due 
to early or persistent antigen after infection has resolved), 
the weighted pfPR of malaria antigenaemia alone was 
12.6%. The weighted prevalence of negative RDT among 
TFM-positive subjects (including two with parasitaemia 
identified only on thin film) was 1.1%. These cases (TFM-
positive and RDT-negative) had lower GMPD of 178.5 
parasites/µL (95% CI 115.0–277.0) than those with of 
current infection (RDT and TFM positive) with GMPD 
of 1912.3 parasites/µL (95% CI 1423.0–2570.0; P < 0.001).
Geographical and seasonal variation in weighted pfPR
Similar to prior studies from this region [20, 34, 35], there 
was no difference in the weighted pfPR estimate for the 
north-central and northwest regions (Fig.  2a). However, 
these similar malaria patterns masked variation in sub-
regional analysis. First, pfPR was a substantially lower 
in IRS than non-IRS sub-regions (32.8 versus 65.7%; 
Fig. 2b). However, the apparent homogeneity in IRS and 
non-IRS sub-regions masked further, substantial varia-
tion in sub-regions in the IRS (3.2–55.3%) and the non-
IRS sub-regions (55.5–75.8%; Fig.  2c). This additional 
variation was not explained by patterns in other covari-
ates (Table  3). As expected, the weighted pfPR (Fig.  3a) 
and the GMPD (Fig. 3b) showed strong seasonal effects, 
both being higher during the wet season than the dry 
seasons, but this pattern was more striking in the high-
density than in the low-density villages.
Weighted pfPR and geometric mean parasite density 
by children’s age
The weighted pfPR increased from 40.0% in children 
1–2 years old to 61.8% in those 6–8 years old and 
decreased slightly to 48.9% in children 12–15  years 
Fig. 2 Map of north-central and northwest regions in Uganda. Showing weighted Plasmodium falciparum parasite prevalence based on the rapid 
diagnostic test in a representative sample of 1142 healthy children 0–15 years old enrolled between January 2011 and April 2015. Panel a pfPR pat-
terns in the two north-central and northwest regions; Panel b pfPR patterns in two sub-regions employing or not IRS; Panel c pfPR patterns in seven 
sub-regions. A inset map is included to show the location of north-central and northwest regions in relation to Kampala, the capital city of Uganda, 
and the location of collaborating hospitals in the study area. It also shows major Ugandan water features (rivers and lakes)
Table 2 Weighted Plasmodium falciparum parasite prevalence according to  the rapid diagnostic test and  thick film 
microscopy among healthy children in northern Uganda
Seven subjects who failed malaria testing were excluded from further analysis. The percentages in each cell are weighted back to the population of size 585,762; the 
numbers in parentheses are the numbers of individuals those percentages are based on
Thick film microscopy Total
Negative Positive
RDT Negative 44.1% (n = 561) 1.1% (n = 12) 45.2% (n = 573)
Positive 12.6% (n = 141) 42.3% (n = 429) 54.8% (n = 570)
Total 56.6% (n = 702) 43.4% (n = 441) 100% (N = 1143) (Nweighted = 585,762)
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Table 3 Plasmodium falciparum parasite prevalence among  apparently healthy children 0–15  years old enrolled 
between January 2011 and April 2015 from the north-central and northwest regions of Uganda
Characteristics Unadjusted P Adjusted* P
Weighted  (%) Odds ratio (95% CI) Odds ratio (95% CI)
All subjects 1142 54.8 – – – –
Age group, years
 0–5 326 52.0 1.00
 6–10 572 58.2 1.29 (0.86–1.93)
 11–15 252 52.3 1.01 (0.56–1.85) 0.185 – –
Sex
 Female 541 55.2 1.00
 Male 609 54.5 0.97 (0.68–1.39) 0.885 – –
Proximity to water
 Far (>500 m) 486 51.6 1.00
 Near (≤500 m) 664 55.2 1.16 (0.63–2.12) 0.631 – –
Population density
 Low (<2683 children) 753 59.1 1.00
 High (≥2683 children) 397 46.0 0.59 (0.29–1.21) 0.151 – –
Season
 Dry season 731 48.7 1.00 1.00
 Wet season 419 69.1 2.35 (1.26–4.40) 0.009 1.81 (0.95–3.46) 0.076
Region
 North-central 697 53.0 1.00
 Northwest 453 57.8 1.21 (0.65–2.28) 0.547 – –
Indoor residual spraying (IRS) sub-region
 Not an IRS district 737 65.7 1.00
 IRS district 413 32.8 0.26 (0.14–0.46) <0.001 – –
Indoor residual spraying (IRS) in house
 More than a year ago 752 64.4 1.00 1.00
 In the past year 392 34.0 0.28 (0.15–0.53) <0.001 0.37 (0.14–1.03) 0.061
Sub-regions
 1 113 60.3 1.00 1.00
 2 289 67.7 1.38 (0.68–2.78) 1.30 (0.66–2.57)
 3 51 29.8 0.28 (0.07–1.15) 0.25 (0.07–0.86)
 4 97 21.9 0.18 (0.08–0.45) 0.43 (0.11–1.62)
 5 303 55.3 0.81 (0.39–1.69) 1.10 (0.44–2.75)
 6 90 3.2 0.02 (0.00–0.10) 0.03 (0.01–0.24)
 7 207 75.8 2.06 (0.77–5.52) <.001 1.12 (0.43–2.89) 0.001
Mother’s education
 Up to primary 4 581 53.6 1.00
 Primary 5 or higher 565 56.4 1.12 (0.78–1.60) 0.551 – –
Mother’s income (Ugandan shillings)
 <30, 000 USHS 560 59.0 1.00 (1.00–1.00) 1.00
 ≥30,000 USHS 585 49.6 0.68 (0.47–1.00) 0.055 0.57 (0.37–0.87) 0.011
Mosquito net used last night
 No 777 54.2 1.00 –
 Yes 366 56.4 1.09 (0.64–1.87) 0.743 –
Inpatient for malaria
 No 725 54.2 1.00
 Past 12 months 150 42.8 0.63 (0.35–1.15)
 More than 12 months 269 63.1 1.45 (0.88–2.39) 0.119 – –
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old (Fig.  4a, b). Using logistic regression to model the 
weighted pfPR across five age categories that were 
previously defined in Emmanuel et  al. (under 2, 3–5, 
6–8, 9–11, 12+  years) [14], the age-specific ORs of 
pfPR were heterogeneous across these age catego-
ries. Compared to children under 2 years old, the ORs 
for pfPR peaked at 2.42 (95% CI 1.26–4.65) in chil-
dren 6–8 years old and then decreased slightly to 1.43 
(95% CI 0.62–3.31) in children 12–15 years old. There 
was a significant linear relationship between age and 
the weighted pfPR (Ptrend  =  0.006) and a significant 
non-linear effect of age on pfPR (Ptrend  =  0.004). 
These contrasting trends are consistent with the idea 
that the weighted pfPR increases with age as children 
become increasingly mobile with age and are more 
likely to be exposed to malaria infection. Conversely, 
increasing age is associated with increasing cumulative 
acquired malaria immunity and the chance that older 
children are more likely to successful resist new infec-
tion. Interestingly, these age trends were masked when 
pfPR across  was modeled across three age categories 
(Table  3, Pheterogeneity  =  0.185), highlighting the 
importance of using finer categories of age to capture 
rapid changes in the trends. Because BL epidemiology 
is characterized by male and rural predominance, the 
age-group specific patterns of pfPR were examined by 
sex and in high- and low-density villages, but no sig-
nificant differences in age-specific patterns were noted 
by sex in the low-density (Fig.  5a) and high-density 
(Fig. 5b) villages. 
Consistent with their asymptomatic status, GMPD 
among the 436 of 441 TFM-positive participants with 
quantitative data was comparatively low at 1805.5 para-
sites/µL (95% CI 1344.6–2424.3). However, GMPD was 
significantly and inversely correlated with age. GMPD 
was higher in children aged  <5 versus ≥10 years old 
(5092.9 parasites/µL, 95% CI 2892.7–8966.8 versus 
983.8 parasites/µL, 95% CI 472.7–2047.4; P  =  0.001), 
consistent with the idea that immunity against malaria 
parasitaemia increases with age among highly exposed 
children.
Association of pfPR with children’s characteristics
In unadjusted analyses, pfPR was positively associ-
ated with enrolment during the wet versus dry season 
(OR 2.35, 95% CI 1.26–4.40), and inversely associated 
with living in a sub-region where IRS was implemented 
versus living in a sub-region where IRS was not imple-
mented (OR 0.26, 95% CI 0.14–0.46). Similar results 
were obtained when exposure to IRS was assessed using 
self-reported questionnaire information about whether 
a child lived or not in a house where IRS was applied in 
the past year (OR 0.28, 95% CI 0.15–0.53), confirming 
the validity of the ecological association between IRS and 
pfPR. The weighted pfPR was inversely associated with a 
child’s mother’s income ≥30,000 versus  <30,000 USHS 
(OR 0.68, 95% CI 0.47–1.00) and positively associated 
with a child reporting outpatient treatment for malaria in 
the past 12 months versus no treatment (OR 1.73, 95% CI 
1.1.0–2.72). However, sex, proximity of village to water, 
population density, region, and mother’s education level, 
sleeping under a mosquito bed net the previous night, or 
history of inpatient malaria treatment were unrelated to 
weighted pfPR (all P  >  0.10). In multivariable analyses, 
including only those variables with P < 0.10 in the unad-
justed analyses, the weighted pfPR remained significantly 
heterogeneous across the seven geographical sub-regions 
(P = 0.001). In addition, the weighted pfPR was inversely 
associated with a child’s mother income (OR 0.57, 95% CI 
0.37–0.87) and with living in an IRS sub-region (OR 0.37, 
95% CI 0.14–1.03), but positively associated with being 
enrolled during the wet season calendar months (OR 
1.81, 95% CI 0.95–3.46). Similar patterns were observed 
when these analyses were repeated using pfPR defined 
based on only TFM or combined positivity TFM and 
RDT results.
Dry season months were January to March and July to August; Wet season months were April to June and September to December. Mother’s income was estimated 
in Ugandan shillings (30,000 Ugandan shillings are approximately equal to 10 US dollars). Final adjusted models included all variables with P < 0.10 (season, IRS of 
insecticide, sub-region, mother’s income, and outpatient malaria treatment). IRS in the sub-region was not included in the model despite its unadjusted P < 0.001, 
since it was highly correlated with IRS in the house
Results with a two-sided P < 0.05 were considered statistically significant and those with P < 0.10 were considered as showing a trend towards significance. These 
results are shown in italics. * The adjusted models were fit including those variables with P < 0.10 in the unadjusted analysis to adjust their effects for each other. The 
significant or suggestive results in the adjusted models are shown in italics
Table 3 continued
Characteristics Unadjusted P Adjusted* P
Weighted  (%) Odds ratio (95% CI) Odds ratio (95% CI)
Outpatient for malaria
 No 523 46.9 1.00 1.00
 Past 12 months 532 60.4 1.73 (1.10–2.72) 1.28 (0.82–2.01)
 More than 12 months 89 52.6 1.26 (0.53–2.99) 0.064 1.00 (0.37–2.69) 0.476
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Discussion
The current study is the largest to present accurate gran-
ular baseline data about geographical and demographical 
patterns of asymptomatic malaria infection in healthy 
children living in a BL-endemic region. As expected, 
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Fig. 3 Bar graphs showing malaria weighted per cent Plasmodium falciparum parasite prevalence. Based on the RDT, by season (wet or dry) in low- 
and high-population density villages (Panel a) and the GMPD/µL among microscopy-positive children by visit season in low- and high-population 
density villages (Panel b) among apparently healthy children enrolled between January 2011 and April 2015 from north-central and northwest 
Uganda. Orange shading is used for dry season months, while blue shading is used for wet season months. Wet and dry seasons based on catego-
rization by the Uganda Bureau of Statistics and generally corresponding to ≥10 days/month for wet months and <10 days/month for dry months. 
The unweighted number of participants in each group is shown
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consistent with the results from previous surveys from 
that region [20, 34, 35]. In agreement with the earlier 
studies, the weighted pfPR in the two neighboring regions 
studied was comparable. However, analysis of sub-
regional patterns revealed 50% lower pfPR in sub-regions 
where IRS was employed compared to those where it was 
not applied, highlighting IRS as a major determinant of 
geographical patterns of malaria. However, substantial, 
significant geographical variation in pfPR was observed 
within IRS and non-IRS sub-regions, underscoring the 
contribution from other poorly understood geographical 
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Fig. 4 Bar graphs showing age-group patterns of weighted per cent Plasmodium falciparum parasite prevalence. Based on the RDT (a) and the 
GMPD/µL (b) among apparently healthy, microscopy-positive children enrolled between January 2011 and April 2015 from north-central and 
northwest Uganda. The unweighted number of participants in each age-group is shown. In b, the solid circle indicates the GMPD, the lines indicate 
the 95% CIs of the GMPD, except for the under 2 years old age group, where the upper boundary is beyond the plotted points. GMPD results were 
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Malaria Results by RDT and TFM:
0-2    3-5    6-8    9-11  12-15 0-2    3-5    6-8    9-11  12-150-2    3-5    6-8    9-11  12-150-2    3-5    6-8    9-11  12-15
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Fig. 5 Bar graphs showing the weighted proportion of children (males and females) positive for Plasmodium falciparum parasite prevalence. 
Among apparently healthy children enrolled between January 2011 and April 2015 from north-central and northwest Uganda from low popula-
tion density villages (a) and high population density villages (b). The left y-axis shows the proportion of children by pfPR results. The right y-axis 
shows the re-weighted population counts of the children represented by the sample in each stratum. The legend and colouring in bars shows pfPR 
categories based on both the RDT and TFM (see "Methods")
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masked by the overall regional-specific pfPR, included 
the entire spectrum of endemicity ranging from hypoen-
demic (1–10%), mesoendemic (pfPR 10–50%), hyper-
endemic (pfPR 50–74%) to holoendemic (pfPR  ≥75%) 
both within IRS and non-IRS sub-regions (Fig.  2c). The 
geographical variation in pfPR patterns observed here is 
likely correlated with the underlying variation in mos-
quito vector population relative to human hosts—the so 
called vector-to-host ratio [36], the prevailing vector spe-
cies, e.g., Anopheles gambiae and Anopheles funestus, and 
their flying and feeding habits [37, 38]. Since recurrent 
immunological challenge from parasitaemia or malaria 
antigenaemia is the malaria exposure of interest in the 
study of BL, knowledge of these geographical patterns in 
pfPR can enable more precise evaluation of associations 
between malaria and BL through matching or adjustment 
on geography as a proxy for malaria pressure.
In addition to the environmental factors noted above, 
the geographical variation in the weighted pfPR might be 
due to genetic variation in prevalent genetic mutations 
like the sickle cell disease polymorphism that has been 
linked to malaria resistance [39]. Interestingly, the sub-
region observed to have the highest pfPR  in this study 
(sub-region 7; Fig. 1c) was also reported to have the high-
est prevalence of the sickle cell trait in northern Uganda 
(18–24%) [40]. This correlation is consistent with pub-
lished literature suggesting positive selection of the sickle 
cell trait in areas of high malaria prevalence [41, 42]. This 
positive correlation could be due to a higher number of 
secondary malaria infections per infected person (also 
called the reproductive number of infection) among sub-
jects with the sickle cell trait compared to those without 
the trait [43]. Specifically, because sickle cell trait carri-
ers typically experience low GMPD infections [44] and 
low GMPD infections are more likely to persist and sup-
port higher rates of gametocyte production and lead to 
higher transmission rates in populations with a high fre-
quency of the sickle cell trait [45]. Interestingly, Gouagna 
and colleagues [46] recently reported that parasites also 
may have adapted to be more efficiently transmitted to 
mosquitoes by persons with genetic variants in human 
haemoglobin gene as compared to non-carriers, thereby 
presenting evidence of parasite adaptation to host genetic 
mutations. This parasite adaptation to the human genetic 
mutations could potentially lead to stronger correlations 
between pfPR and the frequency of sickle cell trait in 
some areas.
Both pfPR and the GMPD were noted to vary with age, 
but in different ways. The weighted pfPR increased with 
age and peaked at ages 6–8 years, then declined slightly. 
Conversely, GMPD peaked quickly in children aged 
under 2, 4–6  years before peak pfPR age, then declined 
rapidly. These contrasting pfPR/GMPD patterns suggest 
that children are exposed to malaria infection at all ages 
and infection is usually successfully established until 
they reach 6–8 years, when the risk of new infection 
decreases. The GMPD patterns, which decrease rapidly 
with age, suggest that high parasite counts are experi-
enced mostly at the young ages when children still lack 
immunity, but infections at older ages occur in the con-
text of immunity to malaria, which suppresses parasitae-
mia [47]. Given the interest in malaria infection as a risk 
factor for BL, the observation that GMPD peaks about 
4–8 years earlier than BL [14] argues against high GMPD 
being the insult that triggers the onset of such a rapidly 
growing tumor [16]. Rather, the occurrence of BL in older 
children, who are more likely to have lower parasitaemia 
(Fig. 4b), suggests that recurrent low-count afebrile para-
sitaemia, probably due to novel allelic variants that cause 
break-through infections in children with established 
immunity [48, 49], may be the underlying malaria anti-
genic insult that triggers the onset of this rapidly growing 
tumor [50]. If so, examination of immune responses to 
malaria or allelic variants in patients with BL and well-
matched controls could reveal both evidence of strong 
exposure to malaria, strong protective immune response 
against malaria, and infection with multi-clonal parasites 
in children with BL.
The observation of an inverse correlation between 
pfPR and the use of IRS agrees with results from national 
malaria indicator surveys conducted in Uganda [21]. 
Similar to those surveys, the current study also found 
that mosquito bed nets, which are widely recommended 
and distributed [51], appear to have had a negligible 
impact on geographical or individual pfPR patterns in 
this region. This lack of impact of mosquito bed nets on 
pfPR in this study, which agrees with reports by others in 
the region [52], may, in part, be due to misclassification 
of responses about bed net use or to their inconsistent 
and/or improper use. However, mosquito bed nets only 
suppress mosquito populations around bed areas, which 
may not lead to community-wide suppression of the vec-
tor-host ratio like IRS. More worrying, the lack of impact 
could be an indicator of emerging pyrethroid resistance 
in this region as has been reported in some studies [53]. If 
so, the lack of impact of mosquito bed nets on geographi-
cal patterns of pfPR should be evaluated more carefully 
to understand its basis and to exclude more serious rea-
sons such as emerging pyrethroid resistance in regional 
mosquito populations.
The strengths of the current study include selecting a 
regionally representative, population-based sample of 
children to generate accurate regional and sub-regional 
statistics of pfPR in a BL-endemic area. The use of RDT, 
which is more sensitive than TFM and provides informa-
tion about population prevalence of malaria infection 
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over a three- to four-week period [33] is a strength. The 
finding of similar patterns of pfPR when using results 
defined by TFM or both TFM and RDT suggests that 
the patterns reported here are likely valid. Only 1.1% 
of participants had false negative RDT results, which is 
similar to prior reports [54]. This percentage is negligible 
for descriptive studies of geographical and demographi-
cal patterns, but the molecular reasons for false nega-
tive results, which may be due to deletions of pfhrp2 or 
pfhrp3  genes that code for the RDT antigens [54], need 
careful evaluation to preserve the value of these tests for 
clinical and epidemiological studies. The limitations of 
this study include relying on recall for information about 
history of outpatient or inpatient malaria treatment, 
which is subject to recall bias. Review of health records at 
health centers was considered to strengthen the results, 
but the quality of records at health centres in rural 
Uganda was found to be unreliable. Another limitation 
is the classification of wet and dry season based on aver-
age rain patterns during the study period, hence there 
might be some misclassification, which would attenuate 
differences.
Conclusions
The study confirmed high but geographically and demo-
graphically heterogeneous malaria prevalence in BL-age 
children residing in northern Uganda. The finding that 
the peak age for pfPR and BL are comparable, while 
GMPD peaks 4–8 years earlier, raises the hypothesis that 
recurrent asymptomatic malaria exposure in children 
with established malarial immunity may be the underly-
ing malaria antigenic insult associated with the onset of 
BL. Understanding the geographical patterns of malaria 
in this BL-endemic area will pave the way for a more 
granular examination of the malaria/BL associations in 
follow-up studies using molecular and immunological 
methods to measure the malaria response in patients 
with and without BL.
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